Go Pro

Varex Imaging (VREX) Competitors

Varex Imaging logo
$18.45 -0.03 (-0.16%)
Closing price 09/23/2026 04:00 PM Eastern
Extended Trading
$18.45 0.00 (0.00%)
As of 07:47 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

VREX vs. BRBR, NVST, TMDX, ATRC, and AXGN

Should you buy Varex Imaging stock or one of its competitors? Varex Imaging's main competitors and comparable companies include BellRing Brands (BRBR), Envista (NVST), TransMedics Group (TMDX), AtriCure (ATRC), and AxoGen (AXGN). Companies are selected based on similarities in market, industry, and size.

How does Varex Imaging compare to BellRing Brands?

Varex Imaging (NASDAQ:VREX) and BellRing Brands (NYSE:BRBR) are related small-cap companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, valuation, earnings, profitability, media sentiment and analyst recommendations.

BellRing Brands has a net margin of 7.28% compared to Varex Imaging's net margin of 2.55%. Varex Imaging's return on equity of 9.19% beat BellRing Brands' return on equity.

Company Net Margins Return on Equity Return on Assets
Varex Imaging2.55% 9.19% 4.13%
BellRing Brands 7.28%-33.04%15.63%

95.0% of BellRing Brands shares are owned by institutional investors. 4.6% of Varex Imaging shares are owned by insiders. Comparatively, 1.5% of BellRing Brands shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, BellRing Brands had 3 more articles in the media than Varex Imaging. MarketBeat recorded 4 mentions for BellRing Brands and 1 mentions for Varex Imaging. Varex Imaging's average media sentiment score of 0.86 beat BellRing Brands' score of 0.00 indicating that Varex Imaging is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Varex Imaging
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
BellRing Brands
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral

Varex Imaging has a beta of 0.96, indicating that its share price is 4% less volatile than the broader market. Comparatively, BellRing Brands has a beta of 0.43, indicating that its share price is 57% less volatile than the broader market.

Varex Imaging presently has a consensus target price of $16.88, indicating a potential downside of 8.54%. BellRing Brands has a consensus target price of $19.82, indicating a potential upside of 134.71%. Given BellRing Brands' stronger consensus rating and higher possible upside, analysts plainly believe BellRing Brands is more favorable than Varex Imaging.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Varex Imaging
0 Sell rating(s)
7 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
BellRing Brands
1 Sell rating(s)
8 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.44

BellRing Brands has higher revenue and earnings than Varex Imaging. BellRing Brands is trading at a lower price-to-earnings ratio than Varex Imaging, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Varex Imaging$844.60M0.92-$70.30M$0.5235.48
BellRing Brands$2.35B0.42$216.20M$1.425.95

Summary

BellRing Brands beats Varex Imaging on 10 of the 16 factors compared between the two stocks.

How does Varex Imaging compare to Envista?

Envista (NYSE:NVST) and Varex Imaging (NASDAQ:VREX) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, profitability, earnings, risk, analyst recommendations and media sentiment.

Envista currently has a consensus price target of $29.86, indicating a potential upside of 25.23%. Varex Imaging has a consensus price target of $16.88, indicating a potential downside of 8.54%. Given Envista's stronger consensus rating and higher probable upside, analysts plainly believe Envista is more favorable than Varex Imaging.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Envista
0 Sell rating(s)
9 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.53
Varex Imaging
0 Sell rating(s)
7 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Envista has a beta of 0.86, indicating that its stock price is 14% less volatile than the broader market. Comparatively, Varex Imaging has a beta of 0.96, indicating that its stock price is 4% less volatile than the broader market.

Envista has a net margin of 3.33% compared to Varex Imaging's net margin of 2.55%. Varex Imaging's return on equity of 9.19% beat Envista's return on equity.

Company Net Margins Return on Equity Return on Assets
Envista3.33% 7.88% 4.33%
Varex Imaging 2.55%9.19%4.13%

In the previous week, Envista had 17 more articles in the media than Varex Imaging. MarketBeat recorded 18 mentions for Envista and 1 mentions for Varex Imaging. Varex Imaging's average media sentiment score of 0.86 beat Envista's score of 0.27 indicating that Varex Imaging is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Envista
1 Very Positive mention(s)
3 Positive mention(s)
10 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Varex Imaging
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Envista has higher revenue and earnings than Varex Imaging. Varex Imaging is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Envista$2.86B1.34$47M$0.5841.11
Varex Imaging$844.60M0.92-$70.30M$0.5235.48

Summary

Envista beats Varex Imaging on 12 of the 15 factors compared between the two stocks.

How does Varex Imaging compare to TransMedics Group?

Varex Imaging (NASDAQ:VREX) and TransMedics Group (NASDAQ:TMDX) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, valuation, profitability, risk, dividends, earnings and analyst recommendations.

Varex Imaging presently has a consensus target price of $16.88, indicating a potential downside of 8.54%. TransMedics Group has a consensus target price of $121.10, indicating a potential upside of 39.20%. Given TransMedics Group's stronger consensus rating and higher probable upside, analysts clearly believe TransMedics Group is more favorable than Varex Imaging.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Varex Imaging
0 Sell rating(s)
7 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
TransMedics Group
1 Sell rating(s)
6 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.33

99.7% of TransMedics Group shares are owned by institutional investors. 4.6% of Varex Imaging shares are owned by insiders. Comparatively, 6.9% of TransMedics Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Varex Imaging has a beta of 0.96, suggesting that its share price is 4% less volatile than the broader market. Comparatively, TransMedics Group has a beta of 1.9, suggesting that its share price is 90% more volatile than the broader market.

TransMedics Group has a net margin of 22.69% compared to Varex Imaging's net margin of 2.55%. TransMedics Group's return on equity of 15.88% beat Varex Imaging's return on equity.

Company Net Margins Return on Equity Return on Assets
Varex Imaging2.55% 9.19% 4.13%
TransMedics Group 22.69%15.88%5.95%

In the previous week, TransMedics Group had 2 more articles in the media than Varex Imaging. MarketBeat recorded 3 mentions for TransMedics Group and 1 mentions for Varex Imaging. Varex Imaging's average media sentiment score of 0.86 beat TransMedics Group's score of 0.22 indicating that Varex Imaging is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Varex Imaging
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
TransMedics Group
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

TransMedics Group has lower revenue, but higher earnings than Varex Imaging. TransMedics Group is trading at a lower price-to-earnings ratio than Varex Imaging, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Varex Imaging$844.60M0.92-$70.30M$0.5235.48
TransMedics Group$668.47M4.50$190.29M$3.8922.37

Summary

TransMedics Group beats Varex Imaging on 13 of the 16 factors compared between the two stocks.

How does Varex Imaging compare to AtriCure?

AtriCure (NASDAQ:ATRC) and Varex Imaging (NASDAQ:VREX) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, valuation, media sentiment, analyst recommendations, dividends and profitability.

AtriCure has a beta of 1.26, meaning that its stock price is 26% more volatile than the broader market. Comparatively, Varex Imaging has a beta of 0.96, meaning that its stock price is 4% less volatile than the broader market.

AtriCure has higher earnings, but lower revenue than Varex Imaging. Varex Imaging is trading at a lower price-to-earnings ratio than AtriCure, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AtriCure$534.53M5.71-$11.45M$0.21285.52
Varex Imaging$844.60M0.92-$70.30M$0.5235.48

In the previous week, AtriCure had 1 more articles in the media than Varex Imaging. MarketBeat recorded 2 mentions for AtriCure and 1 mentions for Varex Imaging. Varex Imaging's average media sentiment score of 0.86 beat AtriCure's score of 0.42 indicating that Varex Imaging is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
AtriCure
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Varex Imaging
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Varex Imaging has a net margin of 2.55% compared to AtriCure's net margin of 1.85%. Varex Imaging's return on equity of 9.19% beat AtriCure's return on equity.

Company Net Margins Return on Equity Return on Assets
AtriCure1.85% 2.34% 1.77%
Varex Imaging 2.55%9.19%4.13%

99.1% of AtriCure shares are held by institutional investors. 4.0% of AtriCure shares are held by company insiders. Comparatively, 4.6% of Varex Imaging shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

AtriCure presently has a consensus target price of $53.30, suggesting a potential downside of 11.11%. Varex Imaging has a consensus target price of $16.88, suggesting a potential downside of 8.54%. Given Varex Imaging's higher possible upside, analysts clearly believe Varex Imaging is more favorable than AtriCure.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AtriCure
0 Sell rating(s)
4 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.75
Varex Imaging
0 Sell rating(s)
7 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Summary

AtriCure beats Varex Imaging on 9 of the 17 factors compared between the two stocks.

How does Varex Imaging compare to AxoGen?

AxoGen (NASDAQ:AXGN) and Varex Imaging (NASDAQ:VREX) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, analyst recommendations, media sentiment, dividends, earnings and risk.

AxoGen has a beta of 1.16, indicating that its share price is 16% more volatile than the broader market. Comparatively, Varex Imaging has a beta of 0.96, indicating that its share price is 4% less volatile than the broader market.

In the previous week, AxoGen had 1 more articles in the media than Varex Imaging. MarketBeat recorded 2 mentions for AxoGen and 1 mentions for Varex Imaging. Varex Imaging's average media sentiment score of 0.86 beat AxoGen's score of 0.51 indicating that Varex Imaging is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
AxoGen
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Varex Imaging
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Varex Imaging has a net margin of 2.55% compared to AxoGen's net margin of -13.36%. Varex Imaging's return on equity of 9.19% beat AxoGen's return on equity.

Company Net Margins Return on Equity Return on Assets
AxoGen-13.36% -8.90% -6.47%
Varex Imaging 2.55%9.19%4.13%

AxoGen has higher earnings, but lower revenue than Varex Imaging. AxoGen is trading at a lower price-to-earnings ratio than Varex Imaging, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AxoGen$225.21M10.34-$15.70M-$0.68N/A
Varex Imaging$844.60M0.92-$70.30M$0.5235.48

AxoGen currently has a consensus price target of $51.56, suggesting a potential upside of 19.01%. Varex Imaging has a consensus price target of $16.88, suggesting a potential downside of 8.54%. Given AxoGen's stronger consensus rating and higher possible upside, analysts clearly believe AxoGen is more favorable than Varex Imaging.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AxoGen
1 Sell rating(s)
1 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.75
Varex Imaging
0 Sell rating(s)
7 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

80.3% of AxoGen shares are owned by institutional investors. 2.4% of AxoGen shares are owned by insiders. Comparatively, 4.6% of Varex Imaging shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

AxoGen and Varex Imaging tied by winning 8 of the 16 factors compared between the two stocks.

Get Varex Imaging News Delivered to You Automatically

Sign up to receive the latest news and ratings for VREX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VREX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VREX vs. The Competition

MetricVarex ImagingHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$778.01M$5.58B$7.32B$13.29B
Dividend YieldN/A1.79%2.52%12.57%
P/E Ratio35.4825.26274.0625.69
Price / Sales0.9271.35637.8178.88
Price / Cash4.7633.0277.8052.76
Price / Book1.575.7810.406.32
Net Income-$70.30M$151.55M$3.49B$359.73M
7 Day Performance-0.49%0.05%-0.69%0.17%
1 Month Performance-0.38%-3.48%-3.18%-3.27%
1 Year Performance50.49%6.41%15.13%5.58%

Varex Imaging Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VREX
Varex Imaging
2.978 of 5 stars
$18.45
-0.2%
$16.88
-8.5%
+51.9%$778.01M$844.60M35.482,400
BRBR
BellRing Brands
4.6404 of 5 stars
$8.95
-2.7%
$19.82
+121.5%
-77.0%$1.04B$2.35B6.29530
NVST
Envista
3.6386 of 5 stars
$24.99
-3.1%
$29.71
+18.9%
+14.4%$4.01B$2.86B43.0412,000
TMDX
TransMedics Group
4.3116 of 5 stars
$88.58
+3.2%
$124.18
+40.2%
-27.8%$3.06B$668.47M22.78898
ATRC
AtriCure
2.0863 of 5 stars
$55.64
-0.3%
$52.00
-6.5%
+63.6%$2.83B$569.62M264.541,350

Related Companies and Tools


This page (NASDAQ:VREX) was last updated on 9/24/2026 by MarketBeat.com Staff.
From Our Partners